Sign Up Today and Learn More About Full-Life Technologies Stock
Invest in or calculate the value of your shares in Full-Life Technologies or other pre-IPO companies through EquityZen, part of Morgan Stanley.
Full-Life Technologies Stock (FUTE)
Full-Life Technologies is a medical company providing development, production, and commercialization of medicines for cancer therapy.
About Full-Life Technologies Stock
Founded
2021
Industries
Science and Engineering, Health Care, Biotechnology
Full-Life Technologies Press Mentions
Stay in the know about the latest news on Full-Life Technologies
Full-Life Technologies Reports Encouraging Preliminary Phase 1 Safety and PSA Decline for FL-020 in mCRPC at ESMO 2026
prnewswire • Oct 23, 2026
Full-Life Technologies Reports Encouraging Preliminary Phase 1 Safety and PSA Decline for FL-020 in mCRPC at ESMO 2026
morningstar • Oct 23, 2026
Full-Life’s [225Ac]Ac-FL-261 cleared for clinic in US, Australia
bioworld • Sep 11, 2026
Full-Life Technologies Announces U.S. FDA IND Clearance and Australian Regulatory Clearance for [²²⁵Ac]Ac-FL-261 Phase 1 Clinical Trial
biospace • Sep 09, 2026
创新型医疗企业「复通汇智」完成数千万元融资融资
news • Aug 11, 2026
Full-Life Technologies Management
Leadership team at Full-Life Technologies
Co-Founder, Chairman & CEO
Lanny Sun
Co-founder & COO
Nicholas Wong
Join now and verify your accreditation status to gain access to:
- Full-Life Technologies Current Valuation
- Full-Life Technologies Stock Price
- Full-Life Technologies Management
- Available deals in Full-Life Technologies and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Full-Life Technologies Cap Table and Funding History by Share Class and Liquidity Preferences
- Full-Life Technologies Revenue and Financials
- Full-Life Technologies Highlights
- Full-Life Technologies Business Model
- Full-Life Technologies Risk Factors
- Full-Life Technologies Research Report from SACRA Research
Trading Full-Life Technologies Stock
How to invest in Full-Life Technologies stock?
Accredited investors can buy pre-IPO stock in companies like Full-Life Technologies through EquityZen funds. These investments are made available by existing Full-Life Technologies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Full-Life Technologies stock?
Shareholders can sell their Full-Life Technologies stock through EquityZen's private company marketplace. EquityZen's network includes over 480K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 57K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
